AN2 Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for AN2 Therapeutics stock has a target of 2.00, which predicts a -38.84% decrease from the current stock price of 3.27.

Price Target: $2.00 (-38.84%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.00	$2.00	$2.00	$2.00
Change	-38.84%	-38.84%	-38.84%	-38.84%

* Price targets were last updated on May 5, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for AN2 Therapeutics is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	0	0	0	0	0	0
Buy	2	2	2	2	2	1
Hold	3	3	3	3	3	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Roy Buchanan JMP Securities	JMP Securities	Buy Maintains $5 → $2	Buy	Maintains	$5 → $2	-38.84%	May 5, 2025
Roy Buchanan Citizens Capital Markets	Citizens Capital Markets	Buy Reiterates $5	Buy	Reiterates	$5	+52.91%	Mar 26, 2025
Roy Buchanan Citizens Capital Markets	Citizens Capital Markets	Buy Reiterates $5	Buy	Reiterates	$5	+52.91%	Feb 25, 2025
Roy Buchanan JMP Securities	JMP Securities	Buy Reiterates $5	Buy	Reiterates	$5	+52.91%	Feb 3, 2025
Roy Buchanan JMP Securities	JMP Securities	Buy Reiterates $5	Buy	Reiterates	$5	+52.91%	Nov 19, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.93

from -1.16

EPS Next Year

-0.82

from -0.93

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-10.64	-2.79	-2.74	-1.72	-1.16	-0.93	-0.82
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.96	-0.84
Avg	-0.93	-0.82
Low	-0.89	-0.78

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.